Adams R (2009) Identification of Essential oil components by gas Chromatography / Quadrupole Mass Spectroscopy. 459
Ahmed MN, Kabidul Azam MN (2014) Traditional Knowledge and Formulations of Medicinal Plants Used by the Traditional Medical Practitioners of Bangladesh to Treat Schizophrenia Like Psychosis. Schizophr Res Treatment 2014:1–10. https://doi.org/10.1155/2014/679810
Aly E, Khajah MA, Masocha W (2020) β-caryophyllene, a CB2-receptor-selective phytocannabinoid, suppresses mechanical allodynia in a mouse model of antiretroviral-induced neuropathic pain. Molecules 25:. https://doi.org/10.3390/molecules25010106
Araújo S, Jose A, Chaves M, et al (2016) Reversal of schizophrenia-like symptoms and immune alterations in mice by immunomodulatory drugs. J Psychiatr Res. https://doi.org/10.1016/j.jpsychires.2016.09.017
Bahi A, Al Mansouri S, Al Memari E, et al (2014) β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice. Physiol Behav 135:119–124. https://doi.org/10.1016/j.physbeh.2014.06.003
Becker A, Grecksch G (2004) Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity. Prog Neuropsychopharmacol Biol Psychiatry 28:1267–77. https://doi.org/10.1016/j.pnpbp.2004.06.019
Bezerra MAC, Leal-Cardoso JH, Coelho-de-Souza AN, et al (2000) Myorelaxant and antispasmodic effects of the essential oil of Alpinia speciosa on rat ileum. Phyther Res 14:549–551. https://doi.org/10.1002/1099-1573(200011)14:7<549::AID-PTR623>3.0.CO;2-T
Bitanihirwe BKY, WOO TUW (2011) Oxidative stress in schizophrenia: An integrated approach
Bošković M, Vovk TT, Kores Plesničar B, et al (2011) Oxidative stress in schizophrenia. Curr Neuropharmacol 9:301–12. https://doi.org/10.2174/157015911795596595
Bowie CR, Harvey PD (2006) Cognitive deficits and functional outcome in schizophrenia. Neuropsychiatr. Dis. Treat. 2:531–536
Braff DL, Light GA (2005) The use of neurophysiological endophenotypes to understand the genetic basis of schizophrenia. Dialogues Clin Neurosci 7:125–35
Burton S (2006) Symptom domains of schizophrenia: the role of atypical antipsychotic agents. J Psychopharmacol 20:6–19. https://doi.org/10.1177/1359786806071237
Campbell M, Young PI, Bateman DN, et al (1999) The use of atypical antipsychotics in the management of schizophrenia. Br J Clin Pharmacol 47:13–22. https://doi.org/10.1046/j.1365-2125.1999.00849.x
Carpenter WT, Davis JM (2012) Another view of the history of antipsychotic drug discovery and development. Mol Psychiatry 17:1168–1173. https://doi.org/10.1038/mp.2012.121
Chatterjee M, Ganguly S, Srivastava M, Palit G (2011) Effect of “chronic” versus “acute” ketamine administration and its “withdrawal” effect on behavioural alterations in mice: Implications for experimental psychosis. Behav Brain Res 216:247–254. https://doi.org/10.1016/j.bbr.2010.08.001
Chompoo J, Upadhyay A, Gima S, et al (2012) Antiatherogenic properties of acetone extract of Alpinia zerumbet seeds. Molecules. https://doi.org/10.3390/molecules17066249
Costall B, Naylor RJ (1974) On catalepsy and catatonia and the predictability of the catalepsy test for neuroleptic activity. Psychopharmacologia 34:233–241
Craveiro AA, Matos FJA, de Alencar JW (1976) A simple and inexpensive steam generator for essential oils extraction. J Chem Educ 53:652. https://doi.org/10.1021/ed053p652
Cuesta MJ, Peralta V, Zarzuela A (2001) Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: A longitudinal study. Schizophr Res 48:17–28. https://doi.org/10.1016/S0920-9964(00)00112-2
da Silva Araújo T, Maia Chaves Filho AJ, Monte AS, et al (2017) Reversal of schizophrenia-like symptoms and immune alterations in mice by immunomodulatory drugs. J Psychiatr Res 84:. https://doi.org/10.1016/j.jpsychires.2016.09.017
De Araújo FYR, De Oliveira GV, Gomes PXL, et al (2011) Inhibition of ketamine-induced hyperlocomotion in mice by the essential oil of Alpinia zerumbet: Possible involvement of an antioxidant effect. J Pharm Pharmacol 63:1103–1110. https://doi.org/10.1111/j.2042-7158.2011.01312.x
De Araújo FYR, Silva MIG, Moura BA, et al (2009) Central nervous system effects of the essential oil of the leaves of Alpinia zerumbet in mice. J Pharm Pharmacol 61:. https://doi.org/10.1211/jpp/61.11.0012
de Araújo FYRFYR, Silva MIGMIG, Moura BABA, et al (2009) Central nervous system effects of the essential oil of the leaves of Alpinia zerumbet in mice. J Pharm Pharmacol 61:1521–7. https://doi.org/10.1211/jpp/61.11.0012
De Araújo Pinho FVS, Coelho-De-Souza AN, Morais SM, et al (2005) Antinociceptive effects of the essential oil of Alpinia zerumbet on mice. Phytomedicine 12:482–486. https://doi.org/10.1016/j.phymed.2004.04.006
Dey A, Das S, Mukherjee A (2016) Possible natural therapeutics against schizophrenia and its acute and treatment resistant forms: a review. J Biol Act Prod from Nat 6:1–24. https://doi.org/10.1080/22311866.2016.1175318
Edris AE (2007) Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: A review. Phyther. Res. 21:308–323
Elmslie JL, Porter RJ, Joyce PR, et al (2009) Comparison of Insulin Resistance, Metabolic Syndrome and Adiponectin in Overweight Bipolar Patients Taking Sodium Valproate and Controls. Aust New Zeal J Psychiatry 43:53–60. https://doi.org/10.1080/00048670802534341
Erta M, Quintana A, Hidalgo J (2012) Interleukin-6, a Major Cytokine in the Central Nervous System. Int J Biol Sci 8:1254–1266. https://doi.org/10.7150/ijbs.4679
Favalli G, Li J, Belmonte-de-Abreu P, et al (2012) The role of BDNF in the pathophysiology and treatment of schizophrenia. J Psychiatr Res 46:1–11. https://doi.org/10.1016/j.jpsychires.2011.09.022
Fernandes BSSS, Gama CS, Maria Ceres??r K, et al (2011) Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: A systematic review and meta-regression analysis. J Psychiatr Res 45:995–1004. https://doi.org/10.1016/j.jpsychires.2011.03.002
Fraga DB, Réus GZ, Abelaira HM, et al (2013) Ketamine alters behavior and decreases BDNF levels in the rat brain as a function of time after drug administration. Rev Bras Psiquiatr 35:262–266. https://doi.org/10.1590/1516-4446-2012-0858
Frohlich J, Van Horn JD (2014) Reviewing the ketamine model for schizophrenia. J Psychopharmacol 28:287–302. https://doi.org/10.1177/0269881113512909
Gaebel W, Stricker J, Riesbeck M (2019) The long-term antipsychotic treatment of schizophrenia: A selective review of clinical guidelines and clinical case examples. Schizophr Res. https://doi.org/https://doi.org/10.1016/j.schres.2019.10.049
Gama CS, Canever L, Panizzutti B, et al (2012) Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia. Schizophr Res 141:162–7. https://doi.org/10.1016/j.schres.2012.08.002
Gobira PH, Ropke J, Aguiar DC, et al (2013) Animal models for predicting the efficacy and side effects of antipsychotic drugs. Rev Bras Psiquiatr 35:S132–S139. https://doi.org/10.1590/1516-4446-2013-1164
Green LC, Goldman P, Tannenbaum SR, Goldman P (1981) Nitrate synthesis in the germfree and conventional rat. Science (80- ) 212:56–58. https://doi.org/10.1126/science.6451927
Harrison P (2004) The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berl) 174:151–62. https://doi.org/10.1007/s00213-003-1761-y
Howes O, McCutcheon R, Stone J (2015) Glutamate and dopamine in schizophrenia: an update for the 21st century. J Psychopharmacol 29:97–115. https://doi.org/10.1177/0269881114563634
Hwang ES, Kim HB, Lee S, et al (2020) Antidepressant-like effects of β-caryophyllene on restraint plus stress-induced depression. Behav Brain Res 380:. https://doi.org/10.1016/j.bbr.2019.112439
Irifune M, Shimizu T, Nomoto M (1991) Ketamine-induced hyperlocomotion associated with alteration of presynaptic components of dopamine neurons in the nucleus accumbens of mice. Pharmacol Biochem Behav 40:399–407. https://doi.org/10.1016/0091-3057(91)90571-I
Javitt DC, Zukin SR, Heresco-Levy U, Umbricht D (2012) Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia. Schizophr Bull 38:958–966. https://doi.org/10.1093/schbul/sbs069
Kapur S, Zipursky R, Jones C, et al (2000) Relationship between dopamine D2 occupancy, clinical response, and side effects: A double-blind PET study of first-episode schizophrenia. Am J Psychiatry. https://doi.org/10.1176/appi.ajp.157.4.514
Kennedy DO, Wightman EL (2011) Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function. Adv Nutr 2:32–50. https://doi.org/10.3945/an.110.000117
Kinkead B, Selz KA, Owens MJ, Mandell AJ (2006) Algorithmically designed peptides ameliorate behavioral defects in animal model of ADHD by an allosteric mechanism. J Neurosci Methods 151:68–81. https://doi.org/10.1016/j.jneumeth.2005.07.015
Lahlou S, Galindo CAB, Leal-Cardoso JH, et al (2002) Cardiovascular effects of the essential oil of Alpinia zerumbet leaves and its main constituent, terpinen-4-ol, in rats: Role of the autonomic nervous system. Planta Med 68:1097–1102. https://doi.org/10.1055/s-2002-36336
Li P, Snyder GL, Vanover KE (2016) Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future. Curr Top Med Chem 16:3385–3403. https://doi.org/10.2174/1568026616666160608084834
Liapi C, Anifantis G, Chinou I, et al (2007) Antinociceptive properties of 1,8-cineole and β- pinene, from the essential oil of Eucalyptus camaldu lensis leaves, in rodents. Planta Med 73:1247–1254. https://doi.org/10.1055/s-2007-990224
Lieberman JA, Girgis RR, Brucato G, et al (2018) Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention. Mol Psychiatry 23:1764–1772. https://doi.org/10.1038/mp.2017.249
Maurice T, Lockhart BP, Privat A (1996) Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction. Brain Res 706:181–93
Meltzer HY, Park S, Kessler R (1999) Cognition, schizophrenia, and the atypical antipsychotic drugs. Proc. Natl. Acad. Sci. U. S. A. 96:13591–13593
Monte a. S, de Souza GC, McIntyre RS, et al (2013a) Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: Possible involvement of antioxidant and nitrergic pathways. J Psychopharmacol 27:1032–1043. https://doi.org/10.1177/0269881113503506
Monte AS, De Souza GC, McIntyre RS, et al (2013b) Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: Possible involvement of antioxidant and nitrergic pathways. J Psychopharmacol 27:. https://doi.org/10.1177/0269881113503506
Monte ASAS, da Silva FERFER, Lima CNDCCN de C, et al (2020) Sex influences in the preventive effects of N-acetylcysteine in a two-hit animal model of schizophrenia. J Psychopharmacol 34:125–136. https://doi.org/10.1177/0269881119875979
Monte ASSAS, De Souza GCGCC, McIntyre RSRSS, et al (2013c) Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: Possible involvement of antioxidant and nitrergic pathways. J Psychopharmacol 27:1032–1043. https://doi.org/10.1177/0269881113503506
Muller N, Schwarz M (2006) Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission. Neurotox Res 10:131–48
NIH (1996) Guide for the Care and Use of Laboratory Animals- Institute of Laboratory Animal Research- National Research Council. Natl Acad Press
Nóbrega FFF, Salvadori MGSS, Masson CJ, et al (2014) Monoterpenoid Terpinen-4-ol Exhibits Anticonvulsant Activity in Behavioural and Electrophysiological Studies. Oxid Med Cell Longev 2014:. https://doi.org/10.1155/2014/703848
Osimo EF, Beck K, Reis Marques T, Howes OD (2019) Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures. Mol Psychiatry 24:549–561. https://doi.org/10.1038/s41380-018-0041-5
Radenovic L, Selakovic V (2005) Differential effects of NMDA and AMPA/kainate receptor antagonists on nitric oxide production in rat brain following intrahippocampal injection. Brain Res Bull 67:133–41. https://doi.org/10.1016/j.brainresbull.2005.06.019
Radyushkin K, Hammerschmidt K, Boretius S, et al (2009) Neuroligin-3-deficient mice: model of a monogenic heritable form of autism with an olfactory deficit. Genes Brain Behav 8:416–425. https://doi.org/10.1111/j.1601-183X.2009.00487.x
Rahmatullah M, Rahman MA, Hossan MS, et al (2010) A pharmacological and phytochemical evaluation of medicinal plants used by the Harbang clan of the Tripura tribal community of Mirsharai area, Chittagong district, Bangladesh. J Altern Complement Med 16:769–85. https://doi.org/10.1089/acm.2009.0497
Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22:659–61. https://doi.org/10.1096/fj.07-9574LSF
Satou T, Kasuya H, Takahashi M, et al (2011) Relationship between duration of exposure and anxiolytic-like effects of essential oil from Alpinia zerumbet. Flavour Fragr J. https://doi.org/10.1002/ffj.2047
Satou T, Murakami S, Matsuura M, et al (2010) Anxiolytic effect and tissue distribution of inhaled Alpinia zerumbet essential oil in mice. Nat Prod Commun. https://doi.org/10.1177/1934578x1000500133
Schwieler L, Larsson MK, Skogh E, et al (2015) Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia--significance for activation of the kynurenine pathway. J Psychiatry Neurosci 40:126–33
Sedlak J, Lindsay RH (1968) Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 25:192–205. https://doi.org/10.1016/0003-2697(68)90092-4
Smith SEP, Li J, Garbett K, et al (2007) Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 27:10695–702. https://doi.org/10.1523/JNEUROSCI.2178-07.2007
Sousa DP de, Nóbrega FFF, Morais LCSL de, Almeida RN de (2015) Evaluation of the Anticonvulsant Activity of Terpinen-4-ol. Zeitschrift für Naturforsch C 64:1–5. https://doi.org/10.1515/znc-2009-1-201
Tan S, Lam WP, Wai MSM, et al (2012) Chronic Ketamine Administration Modulates Midbrain Dopamine System in Mice. PLoS One 7:e43947. https://doi.org/10.1371/journal.pone.0043947
Tu PTB, Tawata S (2015) Anti-oxidant, anti-aging, and anti-melanogenic properties of the essential oils from two varieties of Alpinia zerumbet. Molecules 20:16723–16740. https://doi.org/10.3390/molecules200916723
Turetsky BI, Calkins ME, Light GA, et al (2007) Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr Bull 33:69–94. https://doi.org/10.1093/schbul/sbl060
Vasconcelos GSGS, Ximenes NCNC, de Sousa CNSCNS, et al (2015) Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: Participation of antioxidant, nitrergic and neurotrophic mechanisms. Schizophr Res 165:163–70. https://doi.org/10.1016/j.schres.2015.04.017
Zagrebelsky M, Korte M (2014) Form follows function: BDNF and its involvement in sculpting the function and structure of synapses. Neuropharmacology 76:628–638. https://doi.org/10.1016/j.neuropharm.2013.05.029